Embera NeuroTherapeutics, Inc.
BioSpace1, 2031 Kings Highway
Shreveport, LA 71103
BioSpace1, 2031 Kings Highway
Shreveport, LA 71103
Embera Management Team
Embera Board of Directors
Scientific Advisory Board
- Kathleen Brady, MD, Ph.D.
- George Koob, Ph.D.
- Bruce McCarthy, MD
- Charles O'Brien, MD, Ph.D.
- Rajita Sinha, Ph.D.
Investors
Bruce McCarthy, MD
Dr. McCarthy is the CEO of Afferent Pharmaceuticals a CNS company developing novel treatments for chronic pain. His experience includes over 20 years of neuroscience drug development. including R&D leadership roles at Pfizer, Inc., having served as vice president, neuroscience development. He led neuroscience drug development programs of new molecular entities that included Chantix® for smoking cessation and enhancements to marketed products. Prior to joining Pfizer, he held various roles at Abbott Laboratories from 1997 to 2004, including venture head, where he managed clinical development programs for early-stage neuroscience drug candidates, including ABT-594 (an NNR antagonist for pain). Most recently, as an industry consultant, Dr. McCarthy served as head of development and chief medical officer for several start-up companies including Embera, developing treatments for neurological and psychiatric disorders. Dr. McCarthy received an M.B.A. from Kellogg School of Management, an M.D. from the Johns Hopkins University School of Medicine and a B.S. in biological sciences from Stanford University. He completed his residency in neurology at the University of California, San Francisco.